Original Article
Copyright ©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2484-2495
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2484
Table 6 Maintenance therapy in Crohn's disease following induction of remission or response
Induction therapy
Maintenance therapy
SubjectsRegimenRegimenDuration
1 yr2 yr
Candy et al[55], 1995CDAI > 200PS (diminishing dose) + AZA 12 wkAZA 2.5 mg/kgRemission rate 42% (14/33)
Placebo7% (2/30)
Hanauer et al[56], 2002CDAI ≥ 220Gr (1) and Gr (2)Gr (1) INFX 5 mg/kg every 8 wkRemission rate 25% (28/113)
Responder to a single infusion of infliximabINFX 5 mg/kg at weeks 0, 2, 6Gr (2) INFX 10 mg/kg every 8 wk33% (37/112)
Gr (3) INFX 5 mg/kg then placebo infusion at weeks 2, 6Gr (3) placebo infusion every 8 wk11% (12/110)
Sandborn et al[58], 2005Mild to moderate CDBudesonide 6 mg or 3 mgBudesonide 6 mg or 3 mgRelapse rate 60%-70%
Placebo(In all 3 groups)
Takagi et al[39], 2006Active CDTPN (25 cases), TEN (22 cases),ED (half) + a free diet (half)Relapse rate 26.9% (7/26)
PS (1 case), INFX (3 cases)A free diet64.0% (16/25)
Regueiro et al[59], 2009CD patients who had surgeryIleocolonic resectionINFX 5 mg/kg at weeks 0, 2, 6Remission rate 80% (8/10)
then every 8 wk
Placebo58% (7/13)
Present studyActive CDINFX 5 mg/kg at weeks 0, 2, 6 (16 cases), intestinal resection (5 cases), SSZ (1 case)Semi-vegetarian dietRemission rate 100% (16/16)92%
Omnivorous diet67% (4/6)25%